Information Provided By:
Fly News Breaks for September 25, 2019
CWBHF, CVSI
Sep 25, 2019 | 06:08 EDT
FDA regulation of cannabidiol products is still evolving, adding uncertainty now, and limiting the scope of federally legal products, Piper Jaffray analyst Michael Lavery tells investors in a research note. The analyst believes an FDA framework for a broader set of permissible products is a "significant upcoming catalyst" for CBD companies, as all retailers could stock a wider selection of higher velocity product forms. Further, he expects steps in the process along the way could also be "smaller catalysts in the meantime," potentially including an FDA update this fall. Owning CV Sciences (CVSI) and Charlotte's Web (CWBHF) ahead of this regulatory clarity offers the most upside, Lavery tells investors in a research note. The analyst also expect both companies to pursue up-listing to the Nasadq or New York Stock Exchange, which he sees as a positive catalyst.
News For CVSI;CWBHF From the Last 2 Days
CVSI
Mar 28, 2024 | 11:32 EDT
In this edition of "Rising High," The Fly conducted an exclusive interview with Sundie Seefried, founder and chief executive officer of Safe Harbor Financial (SHFS), a financial services provider to the regulated cannabis industry. Here are some... To see the rest of the story go to thefly.com. See Story Here